Navigation Links
Houston Surgeon Can Now Treat Open Angle Glaucoma During Cataract Surgery
Date:6/14/2013

Houston, TX (PRWEB) June 14, 2013

When it comes to eye care, technology has always played a key role. In the past ten years, cataract surgery has advanced tremendously with developments like the premium intraocular lens implant, which has helped many patients reduce the need for glasses after undergoing cataract surgery.    Dr. Mary Green, M.D., PhD of Eye Excellence, a Cataract and LASIK practice located in Houston Texas, now has a new a new tool in her arsenal for taking care of cataracts, and mild to moderate open-angle glaucoma (OAG) at the same time: the iStent® Trabecular Micro-Bypass (from Glaukos Corporation).

Having received FDA approval, the iStent® is not only the only implant approved for mild to moderate OAG, but also the smallest implant ever approved by the FDA. The device measures only 1 millimeter in length, but is highly efficient in increasing the outflow of fluid. The device allows for safely lowering eye pressure by creating a trabecular micro-bypass into Schlemm’s canal. iStent® is implanted during cataract surgery to treat adults already being treated with a daily regimen of annoying glaucoma eye drops. With iStent®, intraocular pressures are reduced, and it has the potential to reduce or even eliminate the reliance on glaucoma eye drops, which is especially beneficial to OAG patients as they must deal with using two or more types of eye drops everyday to control ocular pressure levels.

Studies have shown that more than 90% of patients do not comply with their ocular medication dosing regimens and nearly 50% discontinue taking their medications before 6 months.

Based on recent FDA studies, Dr. Mary Green of Eye Excellence decided to implement the iStent® into her practice. "We insert the iStent® for open angle glaucoma during cataract surgery, which is nice to take care of two problems with one trip to the Operating Room," says Dr. Green.

If you would like more information on iStent®, contact Eye Excellence at (713) 791-9494 or go to eyeexcellence.com.

About Eye Excellence:

Eye Excellence is a multi-physician ophthalmology practice located in Houston, Texas. They specialize in LASIK, Cornea, and cataract surgery with an emphasis on technology and patient care.

Eye Excellence-Houston, TX 6624 Fannin, Suite 2105 Houston, TX 77030 Phone: 713-791-9494, web: http://www.eyeexcellence.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826950.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neuropsychologist receives University of Houstons highest faculty honor
2. University of Houston Graduate College of Social Work announces partnership with MD Anderson
3. Tired of shaving? Take a pic! Amerejuve MedSpa to Kick-Off Houston's Hairiest Contest
4. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
5. University of Southern Mississippi Professor Collaborates with Houston Police for Eyewitness Research Study
6. Horner Flooring to provide court for the MD Anderson Proton Therapy Showcase in Houston.
7. SA4i Commends Houston’s Premier Eye Doctor Offering Better Night Vision and Glare Control
8. SA4i Congratulates Dr. Brad Patt in Houston: Texas “Super Doctor” for Seventh Consecutive Year
9. Amerejuve Dominates Houston's MedSpa Competition With Rapid Expansion: Houston's #1 MedSpa Opens Eighth Location in Kingwood
10. Renaissance Physician Organization Leading Effort with Greater Houston Healthconnect to Enhance Care Coordination and Patient Outcomes
11. Breath Analyzers Often Unreliable in Houston DWI Cases, Says Attorney Joseph LaBella
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret that ... leads to a host of health issues, including urinary incontinence. However, results published ... discovered that good overall muscle strength in older women, particularly in the abdominal ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Much attention has ... for women who become dependent on opioid painkillers has fallen short. From 1999 until ... to a 237% increase in fatal overdoses in male populations.(1) , The proportion of ...
(Date:2/27/2017)... ... February 27, 2017 , ... This ... diffraction analysis as a tool to characterize particle size distributions in the field ... improved results and novel scientific findings. It describes methods of optimized and standardized ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre (SCHC), ... Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a ... the Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) ... th Annual Healthcare Conference on Monday, March 6, ... MA. A live webcast of Infinity,s presentation ... website at www.infi.com , and will be available ... Infinity,Infinity is an innovative biopharmaceutical company dedicated to advancing ...
(Date:2/27/2017)... A recent research report published by Grand View Research, ... to reach a value of $55.8 billion by 2025. Earlier in ... have legalized marijuana for medical uses. In 2016, states such as ... North Dakota , Ohio and ... in medical applications such as chemotherapies and pain management. The growing ...
(Date:2/27/2017)... Period October – December 2016 Revenues amounted to SEK ... million Result after tax amounted to SEK -16.3 (-6.5) million, ... Cash flow from operating activities amounted to SEK -8.3 (-7.3) million ... Period full year 2016 ... result amounted to SEK -39.5 (-29.5) million Result after tax ...
Breaking Medicine Technology: